HomeVideoParadigm Shift in the Treatment of Diabetes - New Scientific Findings

Paradigm Shift in the Treatment of Diabetes - New Scientific Findings



On September 14th, 2016, Dr. Norman Wong, Chief Scientific Officer of Resverlogix Corp. presented a poster at the 52nd EASD Annual Meeting titled: “Apabetalone (RVX-208) acts on epigenetics to lower Major Adverse Cardiovascular Events (MACE) in diabetes patients with atherosclerosis via microbiome activity.”

source

Previous post
type 1 diabetic
Next post
Health, Didya Know about Toothpaste

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz